Polymer-drug conjugates : linker chemistry, protocols and applications /

Polymer-Drug Conjugates: Linker Chemistry, Protocols and Applications discusses important concepts, fundamentals and prospective applications of 'Linker Chemistry' in a clear-and-concise manner. The book provides vital information on chemical entities binding with the drug-polymer complex...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Madan, Jitender (Editor), Baldi, Ashish (Editor), Chaudhary, Monika (Editor), Chopra, Neetu (Editor)
Format: eBook
Language:English
Published: London : Academic Press, 2023.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Title page
  • Table of Contents
  • Copyright
  • Dedication
  • Contributors
  • Editors
  • Preface
  • Acknowledgment
  • Chapter 1. Drug delivery: The conceptual perspectives and therapeutic applications
  • 1. Introduction
  • 2. Basic fundamentals of targeted drug delivery systems
  • 3. Passive targeting
  • 4. Active targeting
  • 5. Ligands for targeting
  • 6. Endocytosis
  • 7. Need of targeted drug delivery system
  • 8. Targeted drug delivery system by oral and parenteral routes
  • 9. Regulatory challenges of novel drug delivery system
  • 10. Scale-up challenges of targeted drug delivery systems
  • 11. Marketed formulation based on targeted drug delivery systems
  • 12. Conclusion and summary
  • Chapter 2. Rational design of linkers in polymer-drug conjugates
  • 1. Introduction
  • 2. Polymer-drug conjugate
  • 3. Linkers/spacers
  • 4. Conclusion
  • Chapter 3. Exploration of polymers in drug delivery: The structural and functional considerations
  • 1. Introduction
  • 2. Different polymers used in linker chemistry for bioconjugation of drugs
  • 3. Classification of polymers on the basis of their structural and physicochemical behavior
  • 4. Role and function of different polymers used in linker chemistry
  • 5. Selection of polymeric drug delivery system and drug release
  • 6. Some recent developments
  • 7. Conclusion
  • Chapter 4. Chemistry of conjugation in drug delivery: The prospects of biodegradable bonds in polymer-drug conjugates
  • 1. Introduction
  • 2. Characteristics of an ideal polymer
  • 3. Polymer-based drug delivery system
  • 4. Polymers used in preparation of polymer-drug conjugates
  • 5. Drug release from polymer-drug conjugates is pH sensitive
  • 6. Different linkages involved in polymer-drug conjugation
  • 7. Conclusion.
  • Chapter 5. Polymer-drug conjugation using ester and ortho-ester bond: Mechanism, protocols, and applications
  • 1. Introduction
  • 2. Discovery tale of polymer-drug conjugates
  • 3. Insights into ester and orthoester bond as drug-polymer conjugate strategy
  • 4. Ester and orthoester bond: Chemistry and cleavage
  • 5. End group functionalities of ester and orthoester conjugation: Synthetic procedures and applications
  • 6. Conclusion
  • Chapter 6. Polymer-drug linking through amide bonds: the chemistry and applications in drug delivery
  • List of abbreviations
  • 1. Introduction about polymer
  • 2. Polymer-drug conjugates
  • 3. Various polymer-drug linking through amide bond: its chemistry
  • 4. Application of polymer-drug linking through amide bond in drug delivery
  • 5. Conclusion and future aspects with polymer-drug conjugate
  • Chapter 7. Drug-polymer conjugate tailoring by disulfide linkage for controlled and targeted drug delivery
  • 1. Introduction
  • 2. Basic chemistry of disulfide linkage
  • 3. Binding with disulfide linkage
  • 4. Drug delivery by drug-polymer sulfide linkage conjugates
  • 5. Synthetic strategies of polymer-drug conjugates
  • 6. New facile strategy
  • 7. Polymer therapeutics for drug delivery
  • 8. Applications of tailored drug-polymer conjugates by sulfide linkage
  • 9. Failures of disulfide linkage
  • 10. Successful disulfide linkages
  • 11. Challenges and future projections
  • Chapter 8. Thioether linkage chemistry: perspectives and prospects in therapeutic designing
  • List of abbreviations
  • 1. Introduction
  • 2. Paclitaxel/gemcitabine
  • 3. Cyclodextrin hyaluronic acid conjugates
  • 4. Camptothecin-PEG-LHRH drug conjugate
  • 5. BIM-23A760
  • 6. Conclusion
  • Chapter 9. Drug targeting to cancer cells through stimuli-responsive imine bonds: fascinating aspects of site specificity
  • 1. Introduction.
  • 2. Polymeric drug delivery system
  • 3. Shell-sheddable nanoassemblies
  • 4. Core-degradable backbone-multicleavable nanoassemblies
  • 5. Core-degradable pendant-multicleavable nanoassemblies
  • 6. Stimuli-responsive/pH-responsive drug-polymer conjugates for cancer chemotherapy
  • 7. Mechanism of formation of imine bond
  • 8. In vivo fate of pH-responsive drug-polymer conjugates with imine and hydrazone linker
  • 9. Drawbacks of imine and hydrazone linker bond in development of drug-polymer conjugate
  • 10. Applications
  • 11. Polymeric nanoparticles
  • 12. Hydrogels
  • 13. Drug-polymer conjugate (polymeric prodrugs)
  • 14. Polymeric micelles
  • Chapter 10. Carbamate-drug conjugates in drug delivery: structural and mechanistic considerations
  • 1. Introduction
  • 2. Chemistry
  • 3. Methodologies for carbamate bond formation
  • 4. Applications of carbamates in pharmaceutical field
  • Chapter 11. Bonding through phosphodiester moiety: Its implications in pharmaceutical modifications
  • 1. Introduction
  • 2. Phosphodiester-containing biomolecules
  • 3. Chemistry of phosphodiester bond
  • 4. Role of phospholipids in drug delivery
  • 5. Oligonucleotide-phosphodiester conjugates
  • 6. siRNA oligonucleotide conjugates
  • 7. Conclusion
  • Chapter 12. Enzymatically degradable linkers
  • 1. Introduction
  • 2. Chemotherapeutic agents and their therapeutic limitations
  • 3. Concept of cancer targeted polymer-drug conjugates
  • 4. Components of polymer-drug conjugates
  • 5. Design and development of enzyme sensitive nanocarrier-mediated anticancer drug delivery system
  • 6. Conclusion
  • Chapter 13. Dendrimer-drug conjugates
  • List of abbreviations
  • 1. Dendrimers-based drug delivery systems
  • 2. Advantages of dendrimer-drug conjugates
  • 3. Prerequisites for dendrimer-drug conjugates
  • 4. Synthesis strategies of dendrimer-drug conjugates.
  • 5. Dendrimer prodrugs with spacers
  • 6. Applications of dendrimer-drug conjugates
  • 7. Dendrimer-drug conjugates in cancer therapeutics
  • 8. Dendrimer-drug conjugates in inflammatory diseases
  • 9. Conclusion and perspective of developing dendrimer-drug conjugates
  • Chapter 14. Antibody-drug conjugate: Emerging trend for targeted treatment
  • 1. Introduction
  • 2. Antibody-drug conjugates design and its chemistry
  • 3. Conjugation mechanism
  • 4. Mechanism of action
  • 5. Antibody-drug conjugate strategies for treatment of diseases
  • 6. Limitation and potency enhancement of antibody-drug conjugates
  • 7. Clinical implication of ADC
  • 8. Conclusion and future perspective
  • Chapter 15. Drug-polymer conjugates: Challenges, opportunities, and future prospects in clinical trials
  • 1. Introduction
  • 2. Types of polymer-drug conjugates
  • 3. Polymers used in PDC
  • 4. Polymer protein conjugates
  • 5. Preparation of PDCs
  • 6. Analytical methodology
  • 7. Advantages of PDC
  • 8. Applications of PDC
  • 9. Polymer-drug conjugates as a concept for combination therapy
  • 10. Polymer conjugates for new molecular targets are being developed
  • 11. Drug distribution
  • 12. PDC in clinical trials
  • 13. Conclusion and future prospects
  • Index.